Evaluating the Knowledge, Practice, and Regulatory Situation of Veterinary Experts Regarding Counterfeit Veterinary Medications in the Selected Districts of Central Gondar Zone, Ethiopia

References

• Central StatisticL Agency. Ethiopia’s Livestock Systems: overview and Areas of Inquiry; 2021.
   Google Scholar
• Asresie A, Zemedu L, Adigrat E The contribution of livestock sector in Ethiopian economy. Advances in Life Science and Technology www.iiste.org. ISSN 2224-7181 (Paper) ISSN 2225-062X (Online) Vol.29; 2015.
   Google Scholar
• Mouiche MMM, Njingou BZN, Moffo F, Mpouam SE, Feussom JMK, Awah-Ndukum J. Veterinary pharmacovigilance in sub-Sahara Africa context: a pilot study of adverse reactions to veterinary medicine in Cameroon. BMC Vet Res. 2019;15(1):1–8. doi:10.1186/s12917-019-2043-1
   PubMed Web of Science ®Google Scholar
• Brioudes V. Résultats de la conférence continentale de l’OIE sur les produits et médicaments vétérinaires en Afrique. In: Séminaire de formation Points focaux nationaux OIE pour les Produits Vétérinaires. Johannesburg, 8(3), p. 213–217; 2010.
   Google Scholar
• Buowari V. Fake and counterfeit drug: a review. Afrimedic J. 2012;3(2):1–4.
   Google Scholar
• Loosli K, Davis A, Muwonge A, Lembo T, Selvapandiyan A. Addressing antimicrobial resistance by improving access and quality of care—a review of the literature from East Africa. PLoS Negl Trop Dis. 2021;15(7):e0009529. doi:10.1371/journal.pntd.0009529
   PubMed Web of Science ®Google Scholar
• Buckley GJ, Gostin LO Countering the problem of falsified and substandard drugs. 2013.
   Google Scholar
• Davison M. Pharmaceutical Anti-Counterfeiting: Combating the Real Danger from Fake Drugs. John Wiley & Sons; 2011.
   Google Scholar
• Zeru H. Assessment of veterinary drugs regulatory framework in Ethiopia using focus groups. Int J Community Med Public Health. 2020;3(1):123–134.
   Google Scholar
• Ubajaka C, Obi-Okaro A, Emelumadu O, Azumarah M, Ukegbu A, Ilikannu S. Factors associated with drug counterfeit in Nigeria: a twelve year review. Br J Med Med Res. 2016;12(4):1–8. doi:10.9734/BJMMR/2016/21342
   Google Scholar
• Siraj J, Gebre A, Shafi M, Birhan A, Ejeta F, Hambisa S. Health care providers’ knowledge, attitude and practice toward counterfeit medicines in Mizan-Tepi university teaching hospital, South west Ethiopia: a cross-sectional study. Inquiry. 2022;59:00469580221108335. doi:10.1177/00469580221108335
   PubMed Web of Science ®Google Scholar
• Cockburn R, Newton PN, Agyarko EK, Akunyili D, White NJ. The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Med. 2005;2(4):e100. doi:10.1371/journal.pmed.0020100
   PubMed Web of Science ®Google Scholar
• World Animal Health. Counterfeit Medical Products: Report by the Secretariat. Geneva: World Health Organization; 2010.
   Google Scholar
• Seifu A, Kebede E, Bacha B, Melaku A, Setegn T. Quality of albendazole tablets legally circulating in the pharmaceutical market of Addis Ababa, Ethiopia: physicochemical evaluation. BMC Pharmacol Toxicol. 2019;20(1):1–7. doi:10.1186/s40360-019-0299-5
   PubMedGoogle Scholar
• Tefera B, Bacha B, Belew S, et al. Study on identification, assay and organoleptic quality of veterinary medicines in Ethiopia. J Pharm Polic Pract. 2022;15(1):17. doi:10.1186/s40545-022-00410-6
   PubMedGoogle Scholar
• Central Statistical Agency. Central statistical agency of the federal democratic republic of Ethiopia: agricultural samples enumeration statistical abstract. Addis Ababa; 2019.
   Google Scholar
• Teshome D. Prevalence of major skin diseases in ruminants and its associated risk factors at University of Gondar Veterinary Clinic, North West Ethiopia. J Res Dev. 2016;4(1):1–7.
   Google Scholar
• Sholy L, Gard P, Williams S, MacAdam A, Saliba C. Public and pharmacist perceptions towards counterfeit medicine in Lebanon using focus groups. Int J Community Med Public Health. 2018;5(2):489–499. doi:10.18203/2394-6040.ijcmph20180224
   Google Scholar
• Przyswa E. Counterfeit medicines and criminal organisations: IRCAM; [Research Report] IRCAM study report IRCAM. 129 p. ⟨hal-00958233⟩; 2013. Available from: http://www.iracm.com/. Accessed March 22, 2024.
   Google Scholar
• Shahverdi S, Hajimiri M, Pourmalek F, et al. Iranian pharmacists’ knowledge, attitude and practice regarding counterfeit drugs. Iran J Pharm Res. 2012;11(3):963.
   PubMed Web of Science ®Google Scholar
• Bashir A, Galal S, Ramadan A, Wahdan A, El-Khordagui L. Community pharmacists’ perceptions, awareness and practices regarding counterfeit medicines: a cross-sectional survey in Alexandria, Egypt. East Mediterr Health J. 2020;26(5):556–564. doi:10.26719/emhj.19.058
   PubMed Web of Science ®Google Scholar
• Bloom S. Bloom -Taxonomy of Educational Objectives, Handbook 1- Cognitive. Domain-Addison Wesley Publishing Company; 1956:1.
   Google Scholar
• Lartey PA, Graham AE, Lukulay PH, Ndomondo-Sigonda M. Pharmaceutical sector development in Africa: progress to date. Pharm Med. 2018;32(1):1–11. doi:10.1007/s40290-018-0220-3
   Google Scholar
• Health for Animals. Illegal Veterinary Medicines Impact and Effective Control. Report, 5, 123–127; 2017.
   Google Scholar
• Liu R, Lundin S. Falsified medicines: literature review. Work Papers Med Human. 2016;2:1.
   Google Scholar
• Duguma B, Abera B, Muktar Y, Adugna S, Kefyalew H, Mengistu S. Knowledge, attitude and practices about quality and management of anthelmintic drugs in Adea Berga District, Central Ethiopia. J Veter Sci Technol. 2018;11:14.
   Google Scholar
• El-Dahiyat F, Fahelelbom KM, Jairoun AA, Al-Hemyari SS. Combatting substandard and falsified medicines: public awareness and identification of counterfeit medications. Front Public Health. 2021;9:754279. doi:10.3389/fpubh.2021.754279
   PubMed Web of Science ®Google Scholar
• Rahman MS, Yoshida N, Tsuboi H, et al. The health consequences of falsified medicines‐a study of the published literature. Trop Med Int Health. 2018;23(12):1294–1303. doi:10.1111/tmi.13161
   PubMed Web of Science ®Google Scholar
• Goodman C, Kachur SP, Abdulla S, Bloland P, Mills A. Drug shop regulation and malaria treatment in Tanzania—why do shops break the rules, and does it matter? Health Policy Plann. 2007;22(6):393–403. doi:10.1093/heapol/czm033
   PubMed Web of Science ®Google Scholar
• Adigwe OP, Onavbavba G, Wilson DO. Challenges associated with addressing counterfeit medicines in Nigeria: an exploration of pharmacists’ knowledge, practices, and perceptions. Integrat Pharm Res Pract. 2022;11:177–186. doi:10.2147/IPRP.S387354
   PubMed Web of Science ®Google Scholar
• Kelesidis T, Falagas ME. Substandard/counterfeit antimicrobial drugs. Clin Microbiol Rev. 2015;28(2):443–464. doi:10.1128/CMR.00072-14
   PubMed Web of Science ®Google Scholar
• Haji M, Kerbache L, Sheriff KM, Al-Ansari T. Critical success factors and traceability technologies for establishing a safe pharmaceutical supply chain. Meth Protocols. 2021;4(4):85. doi:10.3390/mps4040085
   PubMedGoogle Scholar